Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

132 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Role of infliximab in ulcerative colitis: further questions.
Lees CW, Shand AG, Penman ID, Satsangi J, Arnott ID. Lees CW, et al. Among authors: arnott id. Inflamm Bowel Dis. 2006 Apr;12(4):335-7. doi: 10.1097/01.MIB.0000215095.69869.67. Inflamm Bowel Dis. 2006. PMID: 16633056 No abstract available.
Genetics of the innate immune response in inflammatory bowel disease.
Van Limbergen J, Russell RK, Nimmo ER, Ho GT, Arnott ID, Wilson DC, Satsangi J. Van Limbergen J, et al. Among authors: arnott id. Inflamm Bowel Dis. 2007 Mar;13(3):338-55. doi: 10.1002/ibd.20096. Inflamm Bowel Dis. 2007. PMID: 17206667 Review.
Contribution of the NOD1/CARD4 insertion/deletion polymorphism +32656 to inflammatory bowel disease in Northern Europe.
Van Limbergen J, Russell RK, Nimmo ER, Törkvist L, Lees CW, Drummond HE, Smith L, Anderson NH, Gillett PM, McGrogan P, Hassan K, Weaver LT, Bisset WM, Mahdi G, Arnott ID, Sjöqvist U, Lördal M, Farrington SM, Dunlop MG, Wilson DC, Satsangi J. Van Limbergen J, et al. Among authors: arnott id. Inflamm Bowel Dis. 2007 Jul;13(7):882-9. doi: 10.1002/ibd.20124. Inflamm Bowel Dis. 2007. PMID: 17285593
A retrospective analysis of the efficacy and safety of infliximab as rescue therapy in acute severe ulcerative colitis.
Lees CW, Heys D, Ho GT, Noble CL, Shand AG, Mowat C, Boulton-Jones R, Williams A, Church N, Satsangi J, Arnott ID; Scottish Society of Gastroenterology Infliximab Group. Lees CW, et al. Among authors: arnott id. Aliment Pharmacol Ther. 2007 Aug 1;26(3):411-9. doi: 10.1111/j.1365-2036.2007.03383.x. Aliment Pharmacol Ther. 2007. PMID: 17635376 Free article.
The use of adalimumab in the management of refractory Crohn's disease.
Ho GT, Smith L, Aitken S, Lee HM, Ting T, Fennell J, Lees CW, Palmer KR, Penman ID, Shand AG, Arnott ID, Satsangi J. Ho GT, et al. Among authors: arnott id. Aliment Pharmacol Ther. 2008 Feb 15;27(4):308-15. doi: 10.1111/j.1365-2036.2007.03583.x. Epub 2007 Dec 7. Aliment Pharmacol Ther. 2008. PMID: 18081730 Free article. Clinical Trial.
Autophagy gene ATG16L1 influences susceptibility and disease location but not childhood-onset in Crohn's disease in Northern Europe.
Van Limbergen J, Russell RK, Nimmo ER, Drummond HE, Smith L, Anderson NH, Davies G, Gillett PM, McGrogan P, Weaver LT, Bisset WM, Mahdi G, Arnott ID, Wilson DC, Satsangi J. Van Limbergen J, et al. Among authors: arnott id. Inflamm Bowel Dis. 2008 Mar;14(3):338-46. doi: 10.1002/ibd.20340. Inflamm Bowel Dis. 2008. PMID: 18088053
132 results